Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $621.7500 (2.37%) ($602.7900 - $621.7500) on Fri. Jul. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 78 | Latest Price | $621.7500(2.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) DIA(38%) IWD(35%) SPY(34%) SPLV(33%) | Factors Impacting REGN price | REGN will decline at least -1.02% in a week (0% probabilities). VIXM(-10%) TBT(-9%) UUP(-6%) VXX(-1%) SHY(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $603.15(3.08%) | 10 Day Moving Average | $601.39(3.39%) | 20 Day Moving Average | $587.98(5.74%) | To recent high | -15.8% | To recent low | 13.5% | Market Cap | $65.923b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |